Youcare Pharmaceutical Group Co Ltd
SSE:688658
Youcare Pharmaceutical Group Co Ltd
SSE:688658
Price:
20.67
CNY
0.29%
Market Closed
Market Cap:
¥9.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Youcare Pharmaceutical Group Co Ltd
SSE:688658
|
CN |
|
S
|
Stefanutti Stocks Holdings Ltd
JSE:SSK
|
ZA |
|
Marshall Boya ve Vernik Sanayi AS
IST:MRSHL.E
|
TR |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
DE |
|
UPM-Kymmene Oyj
OMXH:UPM
|
FI |
|
Brinker International Inc
NYSE:EAT
|
US |
|
Jai Balaji Industries Ltd
NSE:JAIBALAJI
|
IN |
|
Hanwha General Insurance Co Ltd
KRX:000370
|
KR |
|
Kurabo Industries Ltd
TSE:3106
|
JP |
Income Statement
Earnings Waterfall
Youcare Pharmaceutical Group Co Ltd
Youcare Pharmaceutical Group Co Ltd
Income Statement
Youcare Pharmaceutical Group Co Ltd
Youcare Pharmaceutical Group Co Ltd
Currency: CNY
| Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||
| Interest Expense |
2
|
1
|
2
|
5
|
7
|
9
|
11
|
13
|
16
|
19
|
21
|
24
|
23
|
0
|
0
|
0
|
|
| Revenue |
4 987
N/A
|
4 763
-4%
|
5 123
+8%
|
4 542
-11%
|
4 770
+5%
|
4 813
+1%
|
3 998
-17%
|
4 196
+5%
|
4 036
-4%
|
3 946
-2%
|
4 230
+7%
|
3 781
-11%
|
3 390
-10%
|
2 998
-12%
|
2 548
-15%
|
2 446
-4%
|
|
| Gross Profit | |||||||||||||||||
| Cost of Revenue |
(1 587)
|
(1 525)
|
(1 614)
|
(1 658)
|
(1 788)
|
(1 799)
|
(1 636)
|
(1 608)
|
(1 633)
|
(1 691)
|
(1 751)
|
(1 625)
|
(1 502)
|
(1 412)
|
(1 336)
|
(1 244)
|
|
| Gross Profit |
3 400
N/A
|
3 238
-5%
|
3 508
+8%
|
2 884
-18%
|
2 981
+3%
|
3 014
+1%
|
2 361
-22%
|
2 589
+10%
|
2 403
-7%
|
2 255
-6%
|
2 480
+10%
|
2 156
-13%
|
1 888
-12%
|
1 586
-16%
|
1 212
-24%
|
1 202
-1%
|
|
| Operating Income | |||||||||||||||||
| Operating Expenses |
(2 817)
|
(2 736)
|
(2 961)
|
(2 564)
|
(2 624)
|
(2 598)
|
(2 229)
|
(2 348)
|
(2 193)
|
(2 114)
|
(2 163)
|
(1 962)
|
(1 862)
|
(1 671)
|
(1 468)
|
(1 418)
|
|
| Selling, General & Administrative |
(2 588)
|
(2 448)
|
(2 624)
|
(2 264)
|
(2 299)
|
(2 303)
|
(1 902)
|
(1 998)
|
(1 834)
|
(1 705)
|
(1 769)
|
(1 579)
|
(1 387)
|
(1 206)
|
(983)
|
(962)
|
|
| Research & Development |
(241)
|
(305)
|
(363)
|
(317)
|
(344)
|
(318)
|
(314)
|
(315)
|
(364)
|
(390)
|
(381)
|
(321)
|
(386)
|
(400)
|
(430)
|
(386)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
(63)
|
0
|
0
|
0
|
(77)
|
0
|
0
|
0
|
(94)
|
0
|
0
|
0
|
(99)
|
|
| Other Operating Expenses |
13
|
16
|
26
|
80
|
19
|
22
|
(12)
|
42
|
5
|
(19)
|
(12)
|
32
|
(89)
|
(64)
|
(55)
|
29
|
|
| Operating Income |
583
N/A
|
502
-14%
|
547
+9%
|
320
-42%
|
357
+12%
|
416
+16%
|
133
-68%
|
241
+82%
|
210
-13%
|
142
-33%
|
317
+124%
|
194
-39%
|
26
-87%
|
(85)
N/A
|
(256)
-201%
|
(216)
+16%
|
|
| Pre-Tax Income | |||||||||||||||||
| Interest Income Expense |
40
|
43
|
40
|
38
|
32
|
26
|
16
|
11
|
6
|
(0)
|
(3)
|
(1)
|
(6)
|
(7)
|
(6)
|
(3)
|
|
| Non-Reccuring Items |
(5)
|
0
|
0
|
0
|
1
|
1
|
1
|
(20)
|
(0)
|
0
|
0
|
(34)
|
0
|
0
|
3
|
(15)
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
(11)
|
0
|
0
|
0
|
(3)
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(2)
|
|
| Total Other Income |
(3)
|
0
|
1
|
2
|
(12)
|
(18)
|
(17)
|
(5)
|
(7)
|
(9)
|
(8)
|
(5)
|
(6)
|
(1)
|
(1)
|
(0)
|
|
| Pre-Tax Income |
615
N/A
|
546
-11%
|
588
+8%
|
350
-41%
|
378
+8%
|
425
+12%
|
133
-69%
|
223
+68%
|
209
-6%
|
133
-37%
|
306
+131%
|
152
-50%
|
14
-91%
|
(93)
N/A
|
(261)
-179%
|
(237)
+9%
|
|
| Net Income | |||||||||||||||||
| Tax Provision |
(78)
|
(72)
|
(79)
|
(11)
|
(18)
|
(20)
|
23
|
(36)
|
(38)
|
(36)
|
(65)
|
(31)
|
(12)
|
(5)
|
19
|
(38)
|
|
| Income from Continuing Operations |
537
|
473
|
509
|
339
|
360
|
405
|
156
|
187
|
171
|
97
|
241
|
121
|
3
|
(99)
|
(242)
|
(275)
|
|
| Income to Minority Interest |
1
|
(1)
|
(2)
|
(4)
|
(3)
|
(3)
|
(4)
|
(3)
|
(2)
|
(1)
|
1
|
2
|
3
|
5
|
8
|
12
|
|
| Net Income (Common) |
539
N/A
|
473
-12%
|
507
+7%
|
335
-34%
|
357
+7%
|
402
+13%
|
152
-62%
|
185
+22%
|
169
-9%
|
96
-43%
|
242
+152%
|
124
-49%
|
5
-96%
|
(94)
N/A
|
(234)
-150%
|
(262)
-12%
|
|
| EPS (Diluted) |
1.2
N/A
|
1.05
-12%
|
1.13
+8%
|
0.74
-35%
|
0.79
+7%
|
0.89
+13%
|
0.34
-62%
|
0.41
+21%
|
0.38
-7%
|
0.21
-45%
|
0.55
+162%
|
0.28
-49%
|
0.01
-96%
|
-0.21
N/A
|
-0.53
-152%
|
-0.59
-11%
|
|
Switch to:
Switch to:
See Also
Discover More
